Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

• Status: Recruiting
• Trial end date: 2021-12-12
• Target enrollment: 0
• Participant gender: All

Summary

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Usama Azhar
• Collaborator: King Edward Medical University
• Treatments: Fluticasone; Montelukast; Xhance

Criteria

Inclusion Criteria:

• Age:02 to 05 Years of Age

• both genders will be included.

• patients diagnosed with allergic rhinitis.

Exclusion Criteria:

• patients older than 05 years of age

• a positive history of HIV,TB,Immune deficiency.

• any nasal structural abnormality i.e.polyps,deviated nasal septum.

• history of frequent nasal bleeding,epistaxis.

• concomitant asthma.